Thomas Luft

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 9

Top Topics

Acute Myeloid Leukemia

Stem Cell Transplantation

Top Venues

Bone marrow transplantation

Intensive care medicine

Blood cancer journal

Nature communications

This page only lists publications with an associated author ORCID identifier.

Publications

Arnon Nagler, Myriam Labopin, Ryszard Swoboda, Thomas Schroeder, Rose-Marie Hamladji, Laimonas Griskevicius, Urpu Salmenniemi, Alessandro Rambaldi, Stephan Mielke, Alexander Dmitrievich Kulagin, Jakob R Passweg, Thomas Luft, Tobias Gedde-Dahl, Edouard Forcade, Grzegorz Helbig, Matthias Stelljes, Cristina Castilla-Llorente, Alexandros Spirydonidis, Eolia Brissot, Fabio Ciceri, Florent Malard
Post-transplant cyclophosphamide, calcineurin inhibitor, and mycophenolate mofetil compared to anti-thymocyte globulin, calcineurin inhibitor, and methotrexate combinations as graft-versus-host disease prophylaxis post allogeneic stem cell transplantation from sibling and unrelated donors in patients with acute myeloid leukemia: a study on behalf of the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation. Bone marrow transplantation 59 (7) (2024)
Arnon Nagler, Myriam Labopin, Ryszard Swoboda, Thomas Schroeder, Rose-Marie Hamladji, Laimonas Griskevicius, Urpu Salmenniemi, Alessandro Rambaldi, Stephan Mielke, Alexander Dmitrievich Kulagin, Jakob R Passweg, Thomas Luft, Tobias Gedde-Dahl, Edouard Forcade, Grzegorz Helbig, Matthias Stelljes, Cristina Castilla-Llorente, Alexandros Spirydonidis, Eolia Brissot, Fabio Ciceri, Florent Malard
Post-transplant cyclophosphamide, calcineurin inhibitor, and mycophenolate mofetil compared to anti-thymocyte globulin, calcineurin inhibitor, and methotrexate combinations as graft-versus-host disease prophylaxis post allogeneic stem cell transplantation from sibling and unrelated donors in patients with acute myeloid leukemia: a study on behalf of the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation. Bone marrow transplantation (2024)
Felix Korell, Zachariah DeFilipp, Nicholas Schreck, Thomas Luft, null null
Validation of pre-conditioning EASIX for prediction of sepsis after allogeneic stem cell transplantation. Intensive care medicine (2023)
Evren Bayraktar, Theresa Graf, Francis A Ayuk, Gernot Beutel, Olaf Penack, Thomas Luft, Nicole Brueder, Gastone C Castellani, H Christian Reinhardt, Nicolaus M Kröger, Dietrich Wilhelm Beelen, Amin T Turki
Data-driven grading of acute graft-versus-host disease. Nature communications 14 (1) (2023)
Felix Korell, Nicholas Schreck, Carsten Müller-Tidow, Peter Dreger, Thomas Luft, null null
Pre-transplant EASIX and sepsis after allogeneic stem cell transplantation. Intensive care medicine 48 (6) (2022)
Mark-Alexander Schwarzbich, Hao Dai, Lambros Kordelas, Dietrich W Beelen, Aleksandar Radujkovic, Carsten Müller-Tidow, Peter Dreger, Thomas Luft
Pre-Transplant Serum Leptin Levels and Relapse of Acute Myeloid Leukemia after Allogeneic Transplantation. International journal of molecular sciences 23 (4) (2022)
Kavita Raj, Dirk-Jan Eikema, Vipul Sheth, Linda Koster, Liesbeth C de Wreede, Didier Blaise, Carmela Di Grazia, Yener Koc, Victoria Potter, Patrice Chevallier, Lucia Lopez-Corral, Depei Wu, Stephan Mielke, Johan A Maertens, Ellen Meijer, Anne Huynh, Jakob Passweg, Thomas Luft, José Antonio Pérez-Simón, Fabio Ciceri, Agnieszka Piekarska, G Hayri Ozsan, Nicolaus M Kröger, Marie Robin, Ibrahim Yakoub Agha
Comparison of outcomes for HLA-matched sibling and haplo-identical donors in Myelodysplastic syndromes: report from the chronic malignancies working party of EBMT. Blood cancer journal 12 (9) (2022)
Thomas Luft, Peter Dreger, Aleksandar Radujkovic
Endothelial cell dysfunction: a key determinant for the outcome of allogeneic stem cell transplantation. Bone marrow transplantation 56 (10) (2021)
Hao Dai, Sivaramakrishna P Rachakonda, Olaf Penack, Igor W Blau, Olga Blau, Aleksandar Radujkovic, Carsten Müller-Tidow, Peter Dreger, Rajiv Kumar, Thomas Luft
Polymorphisms in CXCR3 ligands predict early CXCL9 recovery and severe chronic GVHD. Blood cancer journal 11 (2) (2021)